Effect of noradrenaline on glycerol turnover and lipolysis in the whole body and subcutaneous adipose tissue in humans in vivo

A Kurpad, K Khan, Alexander Graham Calder, S Coppack, K Frayn, I Macdonald, M Elia

    Research output: Contribution to journalArticle

    50 Citations (Scopus)

    Abstract

    1. The effect of infusion of noradrenaline (0.42 mumol min-1 kg-1) on the exchange of nonesterified fatty acids, glycerol and other metabolites across subcutaneous abdominal adipose tissue was investigated in five healthy subjects using an arteriovenous catheterization technique and measurement of adipose tissue blood flow using the 133Xe clearance technique. At the same time, the net rate of fat oxidation in the whole body was assessed by indirect calorimetry, and the turnover of glycerol in the whole body and in subcutaneous adipose tissue was estimated using [5-2H]glycerol, which was administered as a primed constant infusion for 1 h before (basal turnover) noradrenaline administration and continued during the 1 h of noradrenaline infusion. 2. The noradrenaline infusion increased the plasma noradrenaline concentration from a basal value of 0.9 +/- 0.1 to 12.6 +/- 1.2 nmol/(mean +/- SEM) at 60 min. It also increased the arterialized concentration of glycerol by 50% (basal value 81 +/- 11 mumol/l-1) and that of plasma non-esterified fatty acids three-fold (basal value 357 +/- 86 mumol/l). 3. Noradrenaline increased the net release of glycerol by adipose tissue three-fold and that of non-esterified fatty acids three- to four-fold. Although the ratio of non-esterified fatty acid to glycerol release by adipose tissue increased in all subjects from a mean value of 2.7 in the basal period to 3.6 and 3.9 at 50 and 60 min of the noradrenaline infusion, respectively (P <0.02), at no time point did the ratio differ significantly from 3.0.(ABSTRACT TRUNCATED AT 250 WORDS)
    Original languageEnglish
    Pages (from-to)177-184
    Number of pages8
    JournalClinical Science
    Volume86
    Issue number2
    Publication statusPublished - 1 Feb 1994

    Fingerprint

    Lipolysis
    Subcutaneous Fat
    Glycerol
    Norepinephrine
    Adipose Tissue
    Fatty Acids
    Abdominal Subcutaneous Fat
    Indirect Calorimetry
    Nonesterified Fatty Acids
    Catheterization
    Healthy Volunteers
    Fats

    Keywords

    • Acid-Base Equilibrium
    • Adipose Tissue
    • Body Composition
    • Glycerol
    • Hemodynamics
    • Humans
    • Lipolysis
    • Male
    • Norepinephrine
    • Oxygen Consumption
    • Regional Blood Flow

    Cite this

    Kurpad, A., Khan, K., Calder, A. G., Coppack, S., Frayn, K., Macdonald, I., & Elia, M. (1994). Effect of noradrenaline on glycerol turnover and lipolysis in the whole body and subcutaneous adipose tissue in humans in vivo. Clinical Science, 86(2), 177-184.

    Effect of noradrenaline on glycerol turnover and lipolysis in the whole body and subcutaneous adipose tissue in humans in vivo. / Kurpad, A; Khan, K; Calder, Alexander Graham; Coppack, S; Frayn, K; Macdonald, I; Elia, M.

    In: Clinical Science, Vol. 86, No. 2, 01.02.1994, p. 177-184.

    Research output: Contribution to journalArticle

    Kurpad, A, Khan, K, Calder, AG, Coppack, S, Frayn, K, Macdonald, I & Elia, M 1994, 'Effect of noradrenaline on glycerol turnover and lipolysis in the whole body and subcutaneous adipose tissue in humans in vivo', Clinical Science, vol. 86, no. 2, pp. 177-184.
    Kurpad A, Khan K, Calder AG, Coppack S, Frayn K, Macdonald I et al. Effect of noradrenaline on glycerol turnover and lipolysis in the whole body and subcutaneous adipose tissue in humans in vivo. Clinical Science. 1994 Feb 1;86(2):177-184.
    Kurpad, A ; Khan, K ; Calder, Alexander Graham ; Coppack, S ; Frayn, K ; Macdonald, I ; Elia, M. / Effect of noradrenaline on glycerol turnover and lipolysis in the whole body and subcutaneous adipose tissue in humans in vivo. In: Clinical Science. 1994 ; Vol. 86, No. 2. pp. 177-184.
    @article{31af915044b446a5831b4d2d7dcc2fd0,
    title = "Effect of noradrenaline on glycerol turnover and lipolysis in the whole body and subcutaneous adipose tissue in humans in vivo",
    abstract = "1. The effect of infusion of noradrenaline (0.42 mumol min-1 kg-1) on the exchange of nonesterified fatty acids, glycerol and other metabolites across subcutaneous abdominal adipose tissue was investigated in five healthy subjects using an arteriovenous catheterization technique and measurement of adipose tissue blood flow using the 133Xe clearance technique. At the same time, the net rate of fat oxidation in the whole body was assessed by indirect calorimetry, and the turnover of glycerol in the whole body and in subcutaneous adipose tissue was estimated using [5-2H]glycerol, which was administered as a primed constant infusion for 1 h before (basal turnover) noradrenaline administration and continued during the 1 h of noradrenaline infusion. 2. The noradrenaline infusion increased the plasma noradrenaline concentration from a basal value of 0.9 +/- 0.1 to 12.6 +/- 1.2 nmol/(mean +/- SEM) at 60 min. It also increased the arterialized concentration of glycerol by 50{\%} (basal value 81 +/- 11 mumol/l-1) and that of plasma non-esterified fatty acids three-fold (basal value 357 +/- 86 mumol/l). 3. Noradrenaline increased the net release of glycerol by adipose tissue three-fold and that of non-esterified fatty acids three- to four-fold. Although the ratio of non-esterified fatty acid to glycerol release by adipose tissue increased in all subjects from a mean value of 2.7 in the basal period to 3.6 and 3.9 at 50 and 60 min of the noradrenaline infusion, respectively (P <0.02), at no time point did the ratio differ significantly from 3.0.(ABSTRACT TRUNCATED AT 250 WORDS)",
    keywords = "Acid-Base Equilibrium, Adipose Tissue, Body Composition, Glycerol, Hemodynamics, Humans, Lipolysis, Male, Norepinephrine, Oxygen Consumption, Regional Blood Flow",
    author = "A Kurpad and K Khan and Calder, {Alexander Graham} and S Coppack and K Frayn and I Macdonald and M Elia",
    year = "1994",
    month = "2",
    day = "1",
    language = "English",
    volume = "86",
    pages = "177--184",
    journal = "Clinical Science",
    issn = "0143-5221",
    publisher = "Portland Press Ltd.",
    number = "2",

    }

    TY - JOUR

    T1 - Effect of noradrenaline on glycerol turnover and lipolysis in the whole body and subcutaneous adipose tissue in humans in vivo

    AU - Kurpad, A

    AU - Khan, K

    AU - Calder, Alexander Graham

    AU - Coppack, S

    AU - Frayn, K

    AU - Macdonald, I

    AU - Elia, M

    PY - 1994/2/1

    Y1 - 1994/2/1

    N2 - 1. The effect of infusion of noradrenaline (0.42 mumol min-1 kg-1) on the exchange of nonesterified fatty acids, glycerol and other metabolites across subcutaneous abdominal adipose tissue was investigated in five healthy subjects using an arteriovenous catheterization technique and measurement of adipose tissue blood flow using the 133Xe clearance technique. At the same time, the net rate of fat oxidation in the whole body was assessed by indirect calorimetry, and the turnover of glycerol in the whole body and in subcutaneous adipose tissue was estimated using [5-2H]glycerol, which was administered as a primed constant infusion for 1 h before (basal turnover) noradrenaline administration and continued during the 1 h of noradrenaline infusion. 2. The noradrenaline infusion increased the plasma noradrenaline concentration from a basal value of 0.9 +/- 0.1 to 12.6 +/- 1.2 nmol/(mean +/- SEM) at 60 min. It also increased the arterialized concentration of glycerol by 50% (basal value 81 +/- 11 mumol/l-1) and that of plasma non-esterified fatty acids three-fold (basal value 357 +/- 86 mumol/l). 3. Noradrenaline increased the net release of glycerol by adipose tissue three-fold and that of non-esterified fatty acids three- to four-fold. Although the ratio of non-esterified fatty acid to glycerol release by adipose tissue increased in all subjects from a mean value of 2.7 in the basal period to 3.6 and 3.9 at 50 and 60 min of the noradrenaline infusion, respectively (P <0.02), at no time point did the ratio differ significantly from 3.0.(ABSTRACT TRUNCATED AT 250 WORDS)

    AB - 1. The effect of infusion of noradrenaline (0.42 mumol min-1 kg-1) on the exchange of nonesterified fatty acids, glycerol and other metabolites across subcutaneous abdominal adipose tissue was investigated in five healthy subjects using an arteriovenous catheterization technique and measurement of adipose tissue blood flow using the 133Xe clearance technique. At the same time, the net rate of fat oxidation in the whole body was assessed by indirect calorimetry, and the turnover of glycerol in the whole body and in subcutaneous adipose tissue was estimated using [5-2H]glycerol, which was administered as a primed constant infusion for 1 h before (basal turnover) noradrenaline administration and continued during the 1 h of noradrenaline infusion. 2. The noradrenaline infusion increased the plasma noradrenaline concentration from a basal value of 0.9 +/- 0.1 to 12.6 +/- 1.2 nmol/(mean +/- SEM) at 60 min. It also increased the arterialized concentration of glycerol by 50% (basal value 81 +/- 11 mumol/l-1) and that of plasma non-esterified fatty acids three-fold (basal value 357 +/- 86 mumol/l). 3. Noradrenaline increased the net release of glycerol by adipose tissue three-fold and that of non-esterified fatty acids three- to four-fold. Although the ratio of non-esterified fatty acid to glycerol release by adipose tissue increased in all subjects from a mean value of 2.7 in the basal period to 3.6 and 3.9 at 50 and 60 min of the noradrenaline infusion, respectively (P <0.02), at no time point did the ratio differ significantly from 3.0.(ABSTRACT TRUNCATED AT 250 WORDS)

    KW - Acid-Base Equilibrium

    KW - Adipose Tissue

    KW - Body Composition

    KW - Glycerol

    KW - Hemodynamics

    KW - Humans

    KW - Lipolysis

    KW - Male

    KW - Norepinephrine

    KW - Oxygen Consumption

    KW - Regional Blood Flow

    M3 - Article

    VL - 86

    SP - 177

    EP - 184

    JO - Clinical Science

    JF - Clinical Science

    SN - 0143-5221

    IS - 2

    ER -